Showing results (11-20 of 142) with videos related to
Sort By:
Pageof 15
The Lancet. Oncology|February 2, 2013
Targeting developmental pathways in children with cancer: what price success?Lia Gore, James DeGregori, Christopher C PorterSeminars in Oncology|December 19, 2007
Forodesine treatment and post-transplant graft-versus-host disease in two patients with acute leukemia: facilitation of graft-versus-leukemia effect?Lia Gore, Matthias Stelljes, Mattias Stelljes, et al.Integrated Blood Pressure Control|January 27, 2022
Hypertension in Pediatric Acute Lymphoblastic Leukemia Patients: Prevalence, Impact, and Management StrategiesLindsey Murphy, Kelly Maloney, Lia Gore, et al.Journal of Pediatric Hematology/Oncology|April 27, 2013
Pulmonary presentation of relapsed acute myeloid leukemiaLindsey M Hoffman, Lia Gore, Kelly W MaloneyClinical Pharmacology and Therapeutics|March 17, 2025
Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure-Response AnalysisXiaofei Zhou, Diane R Mould, Lia Gore, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentratesJulie Kanter, Samina Y Khan, Marguerite Kelher, et al.Pediatric Blood & Cancer|October 6, 2005
Gefitinib is effective against juvenile pilocytic astrocytoma in vitroNicholas K Foreman, Lia Gore, Daniel Wells, et al.Haematologica|August 2, 2014
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trialsDaniel A Pollyea, Jonathan A Gutman, Lia Gore, et al.British Journal of Haematology|June 14, 2016
Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B-cell malignanciesFarrukh T Awan, Lia Gore, Lei Gao, et al.Current Oncology Reports|October 22, 2008
Pediatric developmental therapies: interesting new drugs now in early-stage clinical trialsMargaret E Macy, Kelly K Sawczyn, Timothy P Garrington, et al.Pageof 15